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Abstract Mortalin has been shown to exhibit differential 
distributions in cells with mortal and immortal phenotypes. In the 
present study, we report mot-2 cDNA cloning from RS-4 cells - 
an immortal clone from CDI-ICR mouse embryonic fibroblasts 
- and the chromosomal assignments of mortalin related genes to 
mouse chromosomes 18 and X by fluorescence in situ hybridiza- 
lion. Similar analysis assigned the gene to chromosome 5q31.1 
in human. 
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~. Introduction 
ment in the life span determining pathways and the mitochon- 
drial targets of the protein are the observations shared by at 
least two of these independent s udies. 
In the present study, we have cloned mortalin cDNA from 
an immortal cell line, RS-4, established from CDI - ICR mouse 
fibroblasts. The cDNA exhibits mot-2 structure similar to the 
cDNA isolated from NIH 3T3 cells and consistent with the 
perinuclear distribution of the protein in these cells. The iso- 
lated 3.0 kb clone is used for mouse and human chromosomal 
assignments of mortalin genes. Fluorescence in situ hybridiza- 
tion assigns the mortalin related genes on mouse chromosomes 
18 and X. In human cells the gene assigns to 5q31.1, the locus 
of a putative tumor suppressor gene involved in myeloid malig- 
nancies. 
A genetic program implicated in the mechanisms that lead 
o cellular senescence, the limited division potential of cells in 
~ulture [1,2], has led to the quest for genes that limit cellular 
i~roliferation potential on the one hand and permit ransformed 
,:ells to divide indefinitely on the other. Subtraction hybridiza- 
tions, differential expression screenings and expression studies 
lave implicated the following genes in cell proliferation control: 
~53, Rb, BTG, prohibitin, SAG and p21 sdi-I [3-9]. Microcell 
nediated chromosome transfer has identified chromosome 1, 
~, 6, 7 and X as carriers of putative senescence genes [9-13]. 
We have earlier shown that mortal and immortal cells exhibit 
lifferential cellular localization of mortalin. All immortal 
~uman as well as mouse cells, tested so far, are devoid of the 
miformly distributed cytosolic form of the protein which is 
:haracterisitic of normal cells [14-16]. Senescent MEF (dou- 
'~ling time > 5 days) were transiently induced to divide by the 
nicroinjection of anti-mortalin antibody. Expression of the 
~'ytosolic form (p66 m°tl) induced senescence in NIH 3T3 cells 
Lhat normally harbor the perinuclear form (p66 mot'2) which dif- 
!~ers from p66 "°'1 by two amino acids [14,17]. This protein has 
,recently been identified by three other independent s udies. It 
0¢as identified and cloned as a peptide-binding protein 74 (PBP- 
74) from antigen presenting cells [18]. It was also cloned as C3H 
aaouse strain specific antigen [19]. It has also been identified 
as one of the mitochondrial target proteins, hsp70-1ike pro- 
~ein, during in vivo nephrotoxicity induced by nephrotoxin 
S-(1,1,2,2-tetrafluoroethyl)-L-cysteine [20]. Lack of heat induci- 
bility of the protein, the presence of a signal peptide, involve- 
*Corresponding author. Fax: (81) (298) 54 6095. 
2. Materials and methods 
2.1. Cell culture, cDNA cloning and sequencing 
Details of fibroblast culture from CDI-ICR mouse, establishment of 
spontaneously immortalized cells from CDI-ICR mouse embryonic 
fibroblasts (CMEF), synthesis and screening of cDNA library, and 
sequencing have been described earlier [14-17]. 
2.2. Chromosome preparation and fluorescence insitu hybridization 
(FISH) 
Mouse and human chromosomes were prepared from lymphocytes 
and peripheral blood, respectively, as described earlier [21]. For replica- 
tion R-banding, cells were treated with thymidine (300 ¢tg/ml) for 14 h 
after 44 h of initial seeding (~0.5 x 106 cells/ml) for mouse and 15.5 h 
after 48 h of initial seeding for human. Cells were washed twice with 
serum free medium and then cultured in BrdU (30 pg/ml) supplemented 
medium for 4 h and 6 h for mouse and human, respectively. Colcemid 
(0.02 ,ug/ml) was added 20-30 min before harvesting. The cells were 
collected by mild centrifugation, treated with 0.075 M KC1, fixed with 
methanol/glacial acetic acid (3 : 1), dropped on glass slide and air-dried. 
The chromosome slides were stained with 1/~g/ml Hoechst 33258 in 
Sorensen's phosphate buffer (pH 6.8) for 5 min, rinsed with 2 x SSC 
and mounted. The slides were exposed for 3.5~ min to a HBO-200 
W/A mercury vapor lamp (Osram) at a distance of about 5 cm, and 
stored at -80°C. 
Mortalin cDNA (3 kb, the isolate from RS-4 cells cDNA library) 
cloned in pBluescript was labeled by nick translation with biotin -16 
dUTP (Boehringer Mannheim, Germany) following the manufacturer's 
directions for FISH studies. The labeled DNA fragments were ethanol 
precipitated by using sonicated salmon sperm DNA and tRNA as 
carriers. Precipitated probe was denatured for 10 rain at 75°C in 100% 
formamide and was mixed with an equal volume of hybridization solu- 
tion to the final concentration f 50% formamide; 2 x SSC, 10% dextra- 
nesulfate and ¢tg/ml BSA-1. The chromosome slides were hardened at 
65°C for 2 h, denatured in 70% formamide, 2 x SSC, pH 7.0, at 70°C 
for 2 min and dehydrated in a 4°C ethanol series and were subjected 
to the probe (20 pl of hybridization mixture containing 200-300 ng 
labeled DNA was put on the denatured slide, covered with parafilm and 
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incubated overnight at 37°C). After 12-15 h, the slides were washed 
with 50% formamide in2 x SSC at 37°C for 20 min and with 2 × SSC 
and 1 × SSC for 20 min each at room temperature. After a rinse in 
4 × SSC the slides were incubated with 3 mg/ml fluoresceinated avidin 
antibody (Vector Labs, Burlingane, CA) in 4 x SSC containing 1% BSA 
for 1 h at 37°C. Washings were performed with 4 × SSC, 0.1% Nonidet 
P-40 in 4 x SSC and 4 x SSC for 5 min each and then stained with 
fluorescein-antigoat IgG (Nordic immunology, Tilburg, The Nether- 
lands) at 1 : 500 dilution for 1 h at 37°C. After washings with 4 x SSC, 
0.1% Nonidet P-40 in 4 x SSC and 4 x SSC for 10 min, the slides were 
rinsed with 2 × SSC and stained with 1 #g/ml propidium iodide. Excita- 
tion at wavelength 450490 nm (Nikon filter set B-2A) and near 365 
nm (UV-2A) were used for observations. Kodak Ektachrome ASA 100 
films were used for photomicrography. 
2.3. Southern blot analysis 
Genomic DNAs from a panel of monochromosomal hybrids with a 
single human chromosome in chinese hamster background were used 
for Southern analysis. BamHI digested DNAs were probed with 2.1 kb 
mortalin cDNA labeled with [o~-32p]dCTP to a specific activity of l 0  7 
cpm/#g DNA according to the standard protocols [22]. 
3. Results and discussion 
We have earlier eported the identification and characteriza- 
tion of mortalin (23-27). cDNA cloning of the cytosolic (mot-l) 
and the perinuclear (mot-2) forms from CMEF and NIH 3T3 
ceils, respectively, has also been reported (17). A 3 kb cDNA 
clone (harboring the full open reading frame for mortalin) is 
presently isolated from RS-4 cells, a spontaneously immortal- 
ized clone derived from CMEF, that show the perinuclear dis- 
tribution of mortalin Upon seqencing it revealed the mot-,? 
structure, A at 1,941 and G at 1,959 bp cDNA positions corre- 
sponding to M618 and G624 amino acid residues. The fact that 
these cells have the perinuclear distribution of mortalin 
strongly suggests that the change from mot-1 (cytosolic protein) 
to mot-2 (perinuclear protein) expression is involved in the 
conversion of the normal cellular phenotype to an immortal 
one. The isolated clone has one kb extended sequence than our 
earlier isolated clones from CMEF and NIH 3T3 cells. The 
extended 3' sequence, however, is found to be completely iden- 
tical to the one reported earlier from Balb/c mouse. An addi- 
tional change ($522F) however, is observed with respect o 
sequence reported by Domanico et al. [18] 
Cytogenetic mapping studies by FISH on mouse chromo- 
somes detected mortalin signals on R positive C band of mouse 
chromosome 18 and band A6 of chromosome X (Fig. 1). The 
location of fluorescence signals were determined as described 
previously [21]. In the case of these cells, strong twin spots on 
both homologues were observed in about 32% out of 86% signal 
positive metaphase preads, the rest showed incomplete signals 
on either or both homologues or twin spots on either homo- 
logue. The signal on X chromosome was weak and was ob- 
served in about 30% of spreads. These observations suggest 
that mortalin related genes are present on chromosome 18 and 
X in mouse. The FISH signals obtained for human chromo- 
some localized the gene to 5q31.1, the signal though somewhat 
less intense than that of the mouse chromosome was observed 
in 22% ofmetaphase preads. To support human chromosomal 
assignment, we also performed mortalin Southern hybridiza- 
tion on monochromosomal hybrid panel containing single 
mouse chromosomes against the chinese hamster background. 
The Chromosome 5 containing hybrid cell line showed addi- 
tional bands of 6 kb and 2 kb (Fig. 2B) and suppport he 
chromosomal ssignment by FISH analysis. The mortalin re- 
lated gene was not detected on human X chromosome either 
by FISH or by monochromosomal hybrid panel analysis. The 
present study adds to the mouse and human genomic maps and 
extends another locus that assigns to mouse 18 and human 5q 
chromosome. The weak intensity of the signal on mouse X 
chromosome, the absence of corresponding signal on human 
chromosome and the earlier eported indication of the presence 
of mortalin related pseudo gene in mouse [28] suggest that the 
signal on mouse X chromosome may correspond to a pseudo 
gene. Earlier, the hsp70 gene family members have been 
mapped to chromosome 2, 12 and 17 in mouse and 1, 6 and 14 
in human [29]. Therefore, mortalin is the first hsp70 family 
member assigned to chromosome 18 in mouse and 5q in 
human. Hukku and Rhim [30] have suggested a role for chro- 
mosome 5 in immortalization and tumorigenesis of human 
rl 
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Fig. 1. Cytogenetic mortalin mapping on mouse chromosomes. The metaphase preads were photographed with B-2A (a,c~), and UV2A (b) filters, 
and show R- and G-banding, respectively. The hybridization signals obtained by biotinylated mortalin probe are indicated by long (chromosome 
18 C band) and short (chromosome X A6 band) arrows. 











Fig. 2. Assignment of mortalin to human chromosome. (A) FISH signals on metaphase preads as seen through B-2A (a,c-e) and B2E (b) filters 
corresponding to R-banding and fluorescein sothiocyanate fluorescence, r spectively, are shown. The signal on chromosome 5 is marked with an 
arrow. (B) Southern hybridization ofgenomic DNAs from a monochromosomal hybrid panel with a mortalin cDNA probe, The lanes with Chinese 
hamster ovary (CHO) cell DNA and the ones along with human chromosome 5, 6, 7, 9, 18, 19 and Y are shown. 6.0 kb and 2,0 kb signals in the 
chromosome 5 lane are indicated with arrows. 
keratinocytes. Furthermore, the transfer of chromosome 5 to 
carcinoma cell lines by microcell fusion has been found to 
suppress their tumorigenic properties [31, 32]. Recently, 5q31.1 
has been identified as a critical common deleted region of chro- 
mosome 5 in multiple myeloid malignancies [33] and therefore 
expected to harbor a putative tumor suppressor gene. One 
possible candidate has been reported as the interferon regula- 
tory factor 1 (IRF-1) which shows anti-proliferative and tumor 
suppressive properties [34]. In this regard, the assignment of
mortalin to 5q31,1, its unique associations with cellular normal 
and immortal phenotypes [14-17] attracts greater interest. We 
have recently found that the immortal human cells assigned to 
four complementation groups for immortality [35] exhibit four 
different types of mortalin immunofluorescence patterns corre- 
sponding to the differential localization of the protein within 
the cell [16]. The study demonstrated that an alteration in the 
mortalin distribution is one common end point of the four 
different paths to immortalization. The isolation of mot-1 
cDNA and mot-2 cDNA by immunoscreenings of cDNA li- 
braries from normal and immortal cells, established from the 
same mouse, support hat these are related to mortal and im- 
mortal phenotypes, respectively. Michikawa et al. [28] have 
reported that the two altered base pairs between mot-1 and 
mot-2 reside in the same exon of the gene thus possibility of the 
differential splicing of the gene to yield different transcripts can 
be ruled out. Since the two changes have also been found to be 
always linked in mouse cells and tissues, so far analyzed, by 
RT-PCR analysis (data not shown), the chance that these can 
arise by mutational events is unlikely. We have also found that 
the transfection of mot-1 cDNA results in the induction of 
mortal phenotype in NIH 3T3 cells whereas transfection of 
mot-2 in these cells is either neutral or induce transformed 
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phenotype at a low frequency ([17] and unpublished observa- 
tions). Such differential activity of the transcripts suggests that 
they are unlikely to represent allelic polymorphisms. The ge- 
netic relation and regulation(s) that control the cytosolic ex- 
pression in normal and the perinuclear expression i  immortal 
mouse cells as well as the genetic routes and relationship be- 
tween the forms of mortalin with different subcellular localiza- 
tion in immortal human cells will be adressed in the future 
study. Nevertheless, the present study describing the chromoso- 
mal assignments of mortalin gene on mouse and human chro- 
mosomes would be helpful in defining its in vivo function(s). 
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